AMERICAN INTERNATIONAL GROUP, INC. - CELLULAR BIOMEDICINE GROUP I ownership

CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 41 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q4 2020$132,000
-2.2%
7,161
-2.8%
0.00%
-100.0%
Q3 2020$135,000
+19.5%
7,368
-2.2%
0.00%0.0%
Q2 2020$113,0000.0%7,535
+5.2%
0.00%0.0%
Q1 2020$113,000
-8.1%
7,163
-5.5%
0.00%
Q4 2019$123,000
+7.9%
7,577
-0.8%
0.00%
Q3 2019$114,000
-10.2%
7,640
-0.7%
0.00%
Q2 2019$127,000
-0.8%
7,694
+4.0%
0.00%
Q1 2019$128,000
-5.2%
7,400
-3.1%
0.00%
-100.0%
Q4 2018$135,000
-3.6%
7,639
-0.8%
0.00%
Q3 2018$140,000
-5.4%
7,697
+1.8%
0.00%
-100.0%
Q2 2018$148,000
+68.2%
7,559
+1.0%
0.00%
Q1 2017$88,000
-4.3%
7,487
+7.1%
0.00%
Q4 2016$92,000
-99.9%
6,991
-0.3%
0.00%
Q3 2016$101,645,000
+21.1%
7,010
+0.1%
0.00%
Q2 2016$83,930,000
-21.6%
7,000
+21.5%
0.00%
Q1 2016$107,000,000
-13.7%
5,7620.0%0.00%
-100.0%
Q4 2015$124,000,000
+126430.6%
5,762
-0.2%
0.00%
Q3 2015$98,000
-100.0%
5,772
+0.1%
0.00%
-100.0%
Q2 2015$216,283,0005,7660.00%
Other shareholders
CELLULAR BIOMEDICINE GROUP I shareholders Q1 2019
NameSharesValueWeighting ↓
PLATINUM INVESTMENT MANAGEMENT LTD 672,885$11,123,0000.26%
AWM Investment Company, Inc. 80,165$1,325,0000.25%
Nikko Asset Management Americas, Inc. 532,318$8,799,0000.17%
ARK Investment Management 314,378$5,197,0000.13%
Sumitomo Mitsui Trust Holdings, Inc. 528,418$8,735,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 32,100$531,0000.01%
Mizuho Securities Co. Ltd. 300$5,0000.01%
GEODE CAPITAL MANAGEMENT, LLC 148,815$2,459,0000.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 18,629$308,0000.00%
STATE OF WISCONSIN INVESTMENT BOARD 16,100$237,0000.00%
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders